InMode to Participate in Upcoming Investor Conferences
InMode (NASDAQ:INMD), a leading global provider of innovative medical technologies, has announced its participation in two upcoming investor conferences in August 2025. The company will attend the 10th Annual Needham Virtual MedTech & Diagnostics Conference on August 11, where CEO Moshe Mizrahy will conduct virtual one-on-one meetings.
Additionally, CFO Yair Malca will participate in the Canaccord 45th Annual Global Growth Conference in Boston on August 12 at 2:30 pm ET, featuring a fireside chat moderated by Caitlin Cronin and investor meetings. A live webcast of the presentation will be available.
InMode (NASDAQ:INMD), un leader globale nelle tecnologie mediche innovative, ha annunciato la sua partecipazione a due conferenze per investitori previste per agosto 2025. L'azienda sarà presente al 10° Annuale Needham Virtual MedTech & Diagnostics Conference l'11 agosto, dove il CEO Moshe Mizrahy terrà incontri virtuali individuali.
Inoltre, il CFO Yair Malca parteciperà al 45° Canaccord Annual Global Growth Conference a Boston il 12 agosto alle 14:30 ET, con una tavola rotonda moderata da Caitlin Cronin e incontri con investitori. La presentazione sarà trasmessa in diretta streaming.
InMode (NASDAQ:INMD), un proveedor global líder en tecnologías médicas innovadoras, ha anunciado su participación en dos próximas conferencias para inversores en agosto de 2025. La compañía asistirá a la 10ª Conferencia Anual Virtual Needham MedTech & Diagnostics el 11 de agosto, donde el CEO Moshe Mizrahy realizará reuniones virtuales individuales.
Además, el CFO Yair Malca participará en la 45ª Conferencia Anual Global de Crecimiento Canaccord en Boston el 12 de agosto a las 2:30 pm ET, con una charla informal moderada por Caitlin Cronin y reuniones con inversores. Habrá una transmisión en vivo de la presentación.
InMode (NASDAQ:INMD)는 혁신적인 의료 기술을 선도하는 글로벌 기업으로, 2025년 8월 예정된 두 개의 투자자 컨퍼런스에 참가할 것이라고 발표했습니다. 회사는 8월 11일 제10회 연례 니드햄 가상 MedTech & Diagnostics 컨퍼런스에 참석하며, CEO 모셰 미즈라히가 1:1 가상 미팅을 진행할 예정입니다.
또한 CFO 야이르 말카는 8월 12일 오후 2시 30분(동부시간) 보스턴에서 열리는 캐나코드 제45회 연례 글로벌 성장 컨퍼런스에 참여하여 케이틀린 크로닌이 진행하는 대담과 투자자 미팅에 참석합니다. 프레젠테이션은 실시간 웹캐스트로 제공됩니다.
InMode (NASDAQ:INMD), un fournisseur mondial de premier plan en technologies médicales innovantes, a annoncé sa participation à deux conférences pour investisseurs prévues en août 2025. La société assistera à la 10e conférence annuelle virtuelle Needham MedTech & Diagnostics le 11 août, où le PDG Moshe Mizrahy tiendra des réunions virtuelles individuelles.
De plus, le CFO Yair Malca participera à la 45e conférence annuelle Canaccord Global Growth à Boston le 12 août à 14h30 ET, avec une discussion informelle animée par Caitlin Cronin et des rencontres avec des investisseurs. Une retransmission en direct de la présentation sera disponible.
InMode (NASDAQ:INMD), ein weltweit führender Anbieter innovativer Medizintechnologien, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im August 2025 angekündigt. Das Unternehmen wird am 10. jährlichen Needham Virtual MedTech & Diagnostics Conference am 11. August teilnehmen, bei dem CEO Moshe Mizrahy virtuelle Einzelgespräche führen wird.
Zusätzlich wird CFO Yair Malca am 45. Canaccord Annual Global Growth Conference in Boston am 12. August um 14:30 Uhr ET teilnehmen, mit einem moderierten Gespräch unter der Leitung von Caitlin Cronin und Investorengesprächen. Eine Live-Webcast der Präsentation wird verfügbar sein.
- None.
- None.
YOKNEAM,
10th Annual Needham Virtual MedTech & Diagnostics Conference
Presenters: Moshe Mizrahy, Chief Executive Officer
Format: Virtual one-on-one meetings
When: Monday, Aug. 11
Canaccord 45th Annual Global Growth Conference
Presenters: Yair Malca, Chief Financial Officer
Format: In-person fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research, and meetings
When: Tuesday, Aug. 12 at 2:30 pm ET
A live webcast of the presentation can be accessed here.
Location:
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2025 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 04, 2025, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-in-upcoming-investor-conferences-302520988.html
SOURCE InMode Ltd.
FAQ
When is InMode (INMD) presenting at the Canaccord Global Growth Conference 2025?
Who will represent InMode at the Needham Virtual MedTech Conference 2025?
How can investors access InMode's presentation at the Canaccord Conference?
What type of session will InMode have at the Canaccord Conference 2025?
